View Older Stories View More Recent Stories

Jul 14, 2020 06:58AM Eyegate Pharma (EYEG) to Move Forward on PE Pivotal Study Following Feedback from FDA Meeting
Jul 14, 2020 06:55AM EyeGate Pharma to Proceed with PE Pivotal Study
Jun 11, 2020 07:00AM Eyegate Pharma (EYEG) Reports Positive Feedback from FDA Regarding Ocular Bandage Gel Packaging
Jun 11, 2020 06:55AM EyeGate Pharma Receives Positive Feedback from FDA Regarding Ocular Bandage Gel Packaging
Jun 1, 2020 06:55AM EyeGate Pharma to Present at Jefferies 2020 Virtual Healthcare Conference
May 6, 2020 04:15PM EyeGate Pharma Reports First Quarter 2020 Financial Results and Provides Business Update
Mar 31, 2020 06:57AM Eyegate Pharma (EYEG) Announces Positive Topline Data in Follow-on Dry Eye Pilot Study
Mar 31, 2020 06:55AM EyeGate Pharma Announces Positive Topline Data in Follow-on Dry Eye Pilot Study
Mar 4, 2020 04:15PM EyeGate Pharma Reports Full Year 2019 Financial Results and Provides Business Update
Jan 6, 2020 06:55AM EyeGate Pharma Completes Enrollment in Follow-on PE Pilot Study
Jan 3, 2020 10:25AM EyeGate Announces Completion of $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Dec 31, 2019 11:05AM Eyegate Pharma (EYEG) Announces $5 Million Registered Direct Offering of Common Stock Priced At-The-Market
Dec 31, 2019 09:25AM EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Dec 17, 2019 06:57AM Eyegate Pharma (EYEG) Receives $1.9 Million from Exercised Warrants
Dec 17, 2019 06:55AM EyeGate Pharma Receives $1.9 Million from Exercised Warrants
Dec 2, 2019 06:56AM Eyegate Pharma (EYEG) Reports Additional Positive Top-Line Data in PRK Pivotal Study
Dec 2, 2019 06:55AM EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study
Nov 22, 2019 06:59AM Eyegate Pharma (EYEG) Hits Primary Endpoint in PRK Pivotal Study
Nov 22, 2019 06:55AM EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study
Nov 7, 2019 06:55AM EyeGate Pharma Reports Third Quarter 2019 Financial Results and Provides Business Update
Oct 9, 2019 07:03AM Eyegate Pharma (EYEG) Reports First Patient Enrollment in Follow-on PE Pilot Study
Oct 9, 2019 07:03AM Eyegate Pharma (EYEG) Reports Complete Randomization in Pivotal Study Using the Ocular Bandage Gel Eye Drop
Oct 9, 2019 06:55AM EyeGate Pharma Completes Randomization in Pivotal Study
Oct 9, 2019 06:55AM EyeGate Pharma Enrolls First Patient in Follow-on PE Pilot Study
Sep 30, 2019 06:57AM Eyegate Pharma (EYEG) Enters Agreement for $1.9 Million Private Placement of Common Stock and Warrants
Sep 30, 2019 06:55AM EyeGate Enters Into Agreement for $1.9 Million Private Placement
Sep 23, 2019 06:55AM EyeGate Pharma Regains Nasdaq Listing Compliance
Sep 16, 2019 06:55AM EyeGate Pharma Reaches 75% Randomization of Patients in Pivotal Study
Aug 29, 2019 12:45PM EyeGate Pharma Announces Reverse Stock Split Effective August 30, 2019
Aug 26, 2019 06:58AM Eyegate Pharma (EYEG) Achieves 50% Randomization of Patients in Pivotal Study Using Ocular Bandage Gel eye drop
Aug 26, 2019 06:55AM EyeGate Pharma Reaches 50% Randomization of Patients in Pivotal Study
Jul 9, 2019 06:57AM Eyegate Pharma (EYEG) Files FDA Submission to Initiate PE Pilot Study Using Ocular Bandage Gel
Jul 9, 2019 06:55AM EyeGate Files FDA Submission to Initiate PE Pilot Study
Jun 26, 2019 07:00AM Eyegate Pharma (EYEG) Reports First Patient Enrolled in PRK Pivotal Study
Jun 26, 2019 06:55AM EyeGate Announces First Patient Enrolled in PRK Pivotal Study
Jun 3, 2019 06:57AM Eyegate Pharma (EYEG) Announces Approval from FDA to Initiate PRK Pivotal Study
Jun 3, 2019 06:55AM EyeGate Receives Approval from FDA to Initiate PRK Pivotal Study
May 14, 2019 06:55AM EyeGate Pharma Receives Positive Nasdaq Listing Determination
May 8, 2019 04:15PM EyeGate Pharma Reports First Quarter 2019 Financial Results and Provides Business Update
May 2, 2019 06:59AM Eyegate Pharma (EYEG) Files IDE for PRK Pivotal Study
May 2, 2019 06:55AM EyeGate Files IDE with FDA for PRK Pivotal Study
Mar 26, 2019 06:58AM Eyegate Pharma (EYEG) Confirms Path to De Novo Filing with FDA
Mar 26, 2019 06:55AM EyeGate Confirms Path to De Novo Filing with FDA
Mar 1, 2019 04:05PM EyeGate Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Business Update
Jan 29, 2019 06:55AM EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City
Jan 29, 2019 06:55AM EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City
Jan 16, 2019 06:56AM Eyegate Pharma (EYEG) Announces March 20 Meeting Date with FDA Regarding Application Strategy for its Ocular Bandage Gel
Jan 16, 2019 06:55AM EyeGate Pharmaceuticals Announces Meeting Date with FDA
Jan 16, 2019 06:55AM EyeGate Pharmaceuticals Announces Meeting Date with FDA
Nov 13, 2018 04:05PM EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
View More Recent Stories View Older Stories